• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管溶栓在髂股静脉深静脉血栓形成治疗中的作用。

Role of Catheter-directed Thrombolysis in Management of Iliofemoral Deep Venous Thrombosis.

机构信息

From the Division of Interventional Radiology, Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St, 1 Silverstein, Philadelphia, PA 19104.

出版信息

Radiographics. 2016 Sep-Oct;36(5):1565-75. doi: 10.1148/rg.2016150138.

DOI:10.1148/rg.2016150138
PMID:27618329
Abstract

The treatment for iliofemoral deep venous thrombosis (DVT) is challenging, as the use of anticoagulation alone can be insufficient for restoring venous patency and thus lead to prolongation of acute symptoms and an increased risk of chronic complications, including venous insufficiency and postthrombotic syndrome (PTS). In these cases, earlier and more complete thrombus removal can ameliorate acute symptoms and reduce long-term sequelae. Endovascular therapies involving the use of pharmacologic, mechanical, and combined pharmacomechanical modalities have been developed to achieve these goals. The most frequently used of these techniques, catheter-directed thrombolysis (CDT), involves the infusion of a thrombolytic agent through a multiple-side-hole catheter placed within the thrombosed vein to achieve high local doses and thereby break down the clot while minimizing systemic thrombolytic agent exposure. Randomized controlled trial results have indicated decreased PTS rates and improved venous patency rates in patients treated with CDT compared with these rates in patients treated with anticoagulation. The use of newer pharmacomechanical techniques, as compared with conventional CDT, reduces procedural times and thrombolytic agent doses and is the subject of ongoing investigations. Endovascular thrombus removal techniques offer a means to improve venous valvular function and decrease the risk of debilitating long-term complications such as PTS and are a promising option for treating patients with iliofemoral DVT. (©)RSNA, 2016.

摘要

髂股型深静脉血栓形成(DVT)的治疗颇具挑战性,因为单独使用抗凝治疗可能不足以恢复静脉通畅,从而导致急性症状持续时间延长,并增加慢性并发症(包括静脉功能不全和血栓后综合征(PTS))的风险。在这些情况下,更早、更完全地清除血栓可以改善急性症状并减少长期后遗症。为了实现这些目标,已经开发了涉及使用药物、机械和联合药物机械等方式的血管内治疗方法。这些技术中最常用的方法是经导管溶栓(CDT),它通过将多侧孔导管放置在血栓形成的静脉内来输注溶栓剂,以实现高局部剂量,从而分解血栓,同时最大限度地减少全身溶栓剂暴露。随机对照试验结果表明,与接受抗凝治疗的患者相比,接受 CDT 治疗的患者 PTS 发生率降低,静脉通畅率提高。与传统 CDT 相比,使用新型药物机械技术可减少手术时间和溶栓剂剂量,这是正在进行的研究的主题。血管内血栓清除技术为改善静脉瓣膜功能和降低 PTS 等致残性长期并发症的风险提供了一种手段,是治疗髂股型 DVT 患者的一种很有前途的选择。(©)RSNA,2016 年。

相似文献

1
Role of Catheter-directed Thrombolysis in Management of Iliofemoral Deep Venous Thrombosis.导管溶栓在髂股静脉深静脉血栓形成治疗中的作用。
Radiographics. 2016 Sep-Oct;36(5):1565-75. doi: 10.1148/rg.2016150138.
2
[Endovascular treatment of acute iliofemoral deep venous thrombosis - our results with catheter-directed thrombolysis and AngioJet].[急性髂股深静脉血栓形成的血管内治疗——我们采用导管直接溶栓和AngioJet的治疗结果]
Magy Seb. 2017 Mar;70(1):24-31. doi: 10.1556/1046.70.2017.1.4.
3
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771).急性髂股静脉血栓形成的导管定向静脉溶栓治疗——CaVenT研究:一项多中心、随机、对照临床试验的原理与设计(NCT00251771)
Am Heart J. 2007 Nov;154(5):808-14. doi: 10.1016/j.ahj.2007.07.010. Epub 2007 Sep 6.
4
Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.下肢深静脉血栓形成伴股腘静脉段受累患者应用组织型纤溶酶原激活物溶栓的评估。
J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):613-620. doi: 10.1016/j.jvsv.2017.04.018. Epub 2017 Jun 21.
5
Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.下肢急性深静脉血栓形成的溶栓策略与标准抗凝治疗的比较。
Cochrane Database Syst Rev. 2021 Jan 19;1(1):CD002783. doi: 10.1002/14651858.CD002783.pub5.
6
[Acute iliofemoral deep venous thrombosis should be treated with catheter-directed thrombolysis].急性髂股深静脉血栓形成应采用导管直接溶栓治疗。
Ugeskr Laeger. 2012 Apr 2;174(14):930-3.
7
Catheter-directed thrombolysis and pharmacomechanical thrombectomy improve midterm outcome in acute iliofemoral deep vein thrombosis.导管定向溶栓和药物机械性血栓切除术可改善急性髂股深静脉血栓形成的中期预后。
J Chin Med Assoc. 2017 Feb;80(2):72-79. doi: 10.1016/j.jcma.2016.08.012. Epub 2016 Dec 23.
8
Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis.导管定向溶栓治疗产后深静脉血栓形成
Acta Obstet Gynecol Scand. 2005 Feb;84(2):155-8. doi: 10.1111/j.0001-6349.2005.00565.x.
9
Thrombolysis for iliofemoral deep venous thrombosis.髂股深静脉血栓形成的溶栓治疗
Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1631-8. doi: 10.1586/14779072.2013.852955.
10
Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis.导管直接溶栓与药物机械性血栓切除术治疗有症状的下肢深静脉血栓形成
Am J Surg. 2006 Dec;192(6):782-8. doi: 10.1016/j.amjsurg.2006.08.045.

引用本文的文献

1
Assessment of Catheter-Directed Thrombolysis and Histotripsy Treatment for Deep Vein Thrombosis.导管定向溶栓和组织粉碎术治疗深静脉血栓形成的评估
J Vasc Interv Radiol. 2025 Jun;36(6):1051-1061.e5. doi: 10.1016/j.jvir.2025.01.044. Epub 2025 Jan 29.
2
Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.治疗性超声应用概述与安全考量:2024年更新
J Ultrasound Med. 2025 Mar;44(3):381-433. doi: 10.1002/jum.16611. Epub 2024 Nov 11.
3
assessment of histotripsy-induced changes in catheter-directed thrombolytic delivery.
组织超声碎裂术对导管定向溶栓给药影响的评估
Front Physiol. 2023 Jun 28;14:1225804. doi: 10.3389/fphys.2023.1225804. eCollection 2023.
4
(More than) doubling down: Effective fibrinolysis at a reduced rt-PA dose for catheter-directed thrombolysis combined with histotripsy.(超过)加倍剂量:降低 rt-PA 剂量的导管定向溶栓联合组织爆破的有效纤维蛋白溶解。
PLoS One. 2022 Jan 4;17(1):e0261567. doi: 10.1371/journal.pone.0261567. eCollection 2022.
5
Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi.评估静脉血栓的组织学特征、影像学标志物和 rt-PA 敏感性。
Sci Rep. 2021 Nov 23;11(1):22805. doi: 10.1038/s41598-021-02030-7.
6
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug.一种用于评估超声空化溶栓和溶酶药物溶栓效果的体外系统。
J Vis Exp. 2021 Jun 4(172). doi: 10.3791/62133.
7
Clot Degradation Under the Action of Histotripsy Bubble Activity and a Lytic Drug.组织声击穿气泡活动和溶瘤药物作用下的血栓降解。
IEEE Trans Ultrason Ferroelectr Freq Control. 2021 Sep;68(9):2942-2952. doi: 10.1109/TUFFC.2021.3052393. Epub 2021 Aug 27.
8
Outcome of Acute Deep Venous Thrombosis Using Standard Treatment versus Thrombolytics: A Literature Review.急性深静脉血栓形成采用标准治疗与溶栓治疗的结局:文献综述
Int J Hematol Oncol Stem Cell Res. 2019 Oct 1;13(4):201-207.
9
Endovascular Therapy for Lower Extremity Chronic Deep Venous Occlusive Disease: State of Practice.下肢慢性深静脉闭塞性疾病的血管内治疗:实践现状
Semin Intervent Radiol. 2018 Oct;35(4):333-341. doi: 10.1055/s-0038-1669963. Epub 2018 Nov 5.
10
Pathogenesis of Thromboembolism and Endovascular Management.血栓栓塞的发病机制与血管内治疗
Thrombosis. 2017;2017:3039713. doi: 10.1155/2017/3039713. Epub 2017 Jan 5.